All News from PR Newswire

Thai Newswire x PR Newswire

ภาษาไทย | English
CISION PR Newswire - Gan & Lee Pharmaceuticals Signs Exclusive License Agreement with JW Pharmaceutical, the Leading South Korean Pharma, to Advance the Global Commercialization of the Innovative GLP-1 Receptor Agonist Bofanglutide
PR Newswire

PR Newswire - Gan & Lee Pharmaceuticals Signs Exclusive Lice...

BEIJING and BRIDGEWATER, N.J., April 9, 2026 /PRNewswire/ -- Gan & Lee Pharmaceuticals (h...

Read more
CISION PR Newswire - NYSE Content Update: Fourth Annual NYSE Sustainability Leaders Summit to Commence
PR Newswire

PR Newswire - NYSE Content Update: Fourth Annual NYSE Sustainabi...

NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, April 9, 202...

Read more
CISION PR Newswire - J.S. Held Strengthens Cross-Disciplinary Response to Artificial Intelligence (AI) Disputes
PR Newswire

PR Newswire - J.S. Held Strengthens Cross-Disciplinary Response ...

Delivering technical clarity, financial calculus, and courtroom credibility in AI-related lit...

Read more
CISION PR Newswire - Nancy L. Lewis, MD, MBS, FACP, Named New Chief Scientific Officer for National Comprehensive Cancer Network (NCCN)
PR Newswire

PR Newswire - Nancy L. Lewis, MD, MBS, FACP, Named New Chief Sci...

Accomplished medical research leader will oversee NCCN programs to advance clinical trials an...

Read more
CISION PR Newswire - MindHYVE.ai™ and the Development Authority of LaGrange Announce Strategic Collaboration to Advance AI-Powered Workforce Development in Georgia
PR Newswire

PR Newswire - MindHYVE.ai™ and the Development Authority of LaGr...

Partnership brings adaptive AI upskilling to Georgia's top-ranked economic development commun...

Read more
CISION PR Newswire - GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era
PR Newswire

PR Newswire - GenScript and Mimulus Partner to Industrialize DNA...

The multi-year collaboration aims to scale molecular data storage infrastructure and unlock b...

Read more
CISION PR Newswire - DualityBio Announces China NMPA Acceptance of Biologics License Application Seeking Approval for Trastuzumab Pamirtecan for the Treatment of Unresectable or Metastatic HER2-Positive Adult Breast Cancer
PR Newswire

PR Newswire - DualityBio Announces China NMPA Acceptance of Biol...

SHANGHAI, April 9, 2026 /PRNewswire/ -- DualityBio ("DualityBio" or the "Company", Stock Code: 9606....

Read more
CISION PR Newswire - Terra Quantum AG to go public in $3.25 billion SPAC deal
PR Newswire

PR Newswire - Terra Quantum AG to go public in $3.25 billion SPA...

Strategic go-public transaction aims to accelerate growth in quantum technologies and expand global ...

Read more
CISION PR Newswire - Businesses face sustained pressure in 2026 as global insolvencies rise 3%, Atradius forecasts
PR Newswire

PR Newswire - Businesses face sustained pressure in 2026 as glob...

AMSTERDAM, April 9, 2026 /PRNewswire/ -- Atradius forecasts a further rise in insolvencies in...

Read more
CISION PR Newswire - Phemex TradFi Crude Oil Trading Surges 300% as Ceasefire Volatility Sparks Record Demand
PR Newswire

PR Newswire - Phemex TradFi Crude Oil Trading Surges 300% as Cea...

APIA, Samoa, April 9, 2026 /PRNewswire/ -- Phemex, a user-first crypto exchange, reported tha...

Read more
CISION PR Newswire - OncoC4 announces first participant's dosing in Phase 1/2 clinical trial of ONC-841 for the treatment of Alzheimer's disease
PR Newswire

PR Newswire - OncoC4 announces first participant's dosing in Pha...

ROCKVILLE, Md., April 9, 2026 /PRNewswire/ -- OncoC4 Inc., a late clinical stage biopharmaceu...

Read more
CISION PR Newswire - Exito Media Concepts Announces the 34th Edition of the BFSI IT Summit Indonesia 2026
PR Newswire

PR Newswire - Exito Media Concepts Announces the 34th Edition of...

Tech it to the Next Level: Shaping the Future of Indonesia's BFSI 16th April 2026  |  JW Marriott Me...

Read more
Total : 34,361 Posts
1 ... 540 541 542 ... 2864
The information provided in this article was created by CISION PR Newswire, our news partner. The author's opinions and the content shared on this page are their own and may not necessarily represent the perspectives of Thai Newswire.